Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys.

Circulation research - 14 Jun 2002

Egashira Kensuke, Zhao Qingwei, Kataoka Chu, Ohtani Kishou, Usui Makoto, Charo Israel F, Nishida Ken-Ichi, Inoue Shujiro, Katoh Makoto, Ichiki Toshihiro, Takeshita Akira

Abstract excerpt

Neointimal hyperplasia is a major cause of restenosis after coronary intervention. Because vascular injury is now recognized to involve an inflammatory response, monocyte chemoattractant protein-1 (MCP-1) might be involved in underlying mechanisms of restenosis. In the present study, we demonstrate the important role of MCP-1 in neointimal hyperplasia after cuff-induced arterial injury. In the first set of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CCL2
Share to Femoral Artery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperplasia

Share to Macaca fascicularis

Share to Plasmids

Share to Receptors, CCR2

Share to Receptors, Chemokine

Share to Tunica Intima

Source

Identifiers

PMID: 12065319
DOI: 10.1161/01.res.0000020561.03244.7e

Genes

CCR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys.PMID 12065319Read ↗

Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys.Semantic proximity Read ↗

Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.Semantic proximity Read ↗

Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.Semantic proximity Read ↗

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis.Semantic proximity Read ↗

New Anti–Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E–Knockout MiceSemantic proximity Read ↗

Direct Evidence for P2Y2 Receptor Involvement in Vascular Response to Injury.Semantic proximity Read ↗

Monocyte chemoattractant protein-1 (MCP-1): an overview.Semantic proximity Read ↗

Novel TNF-α receptor 1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice.Semantic proximity Read ↗

Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels.Semantic proximity Read ↗

Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury.Semantic proximity Read ↗

Evidence for a role of macrophage migration inhibitory factor in vascular disease.Semantic proximity Read ↗

Role of macrophage-derived hypoxia-inducible factor (HIF)-1α as a mediator of vascular remodelling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.